Your browser doesn't support javascript.
loading
The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress.
Parlar, Ali; Arslan, Seyfullah Oktay; Dogan, Muhammed Fatih; Çam, Saliha Aysenur; Yalçin, Alper; Elibol, Ebru; Özer, Mehmet Kaya; Üçkardes, Fatih; Kara, Halil.
Afiliación
  • Parlar A; Department of Pharmacology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
  • Arslan SO; Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey.
  • Dogan MF; Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey.
  • Çam SA; Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey.
  • Yalçin A; Department of Histology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
  • Elibol E; Department of Histology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
  • Özer MK; Department of Pharmacology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
  • Üçkardes F; Department of Biostatistics, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
  • Kara H; Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey.
Exp Ther Med ; 16(6): 4900-4908, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30542446
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Exp Ther Med Año: 2018 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Exp Ther Med Año: 2018 Tipo del documento: Article País de afiliación: Turquía